V5P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vytrus Biotech SA

Watchlist Manager

Watchlist

Price: 14.75 EUR Market Closed

Market Cap: €159.2m

	Vytrus Biotech SA F:V5P	ES
	Odfjell SE OTC:ODJBF	NO
	AudioEye Inc NASDAQ:AEYE	US

Profitability Summary

Vytrus Biotech SA's profitability score is 75/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

84% > 81%

Exceptional Operating Margin

38%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

14% > 38%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

18% > 35%

Exceptional Free Cash Flow Margin

15%

Sustainable 3Y Average Free Cash Flow Margin

10%

Free Cash Flow Margin is Increasing

-20% > 15%

Exceptional ROE

33%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

12% > 30%

View All

Hide

Collapse

75 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.